Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Glander

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|May 28, 2004
Review of the immunosuppressant enteric-coated mycophenolate sodiumKlemens Budde, Petra Glander, Fritz Diekmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2010
The 'blood group O problem' in kidney transplantation--time to change?Petra Glander, Klemens Budde, Danilo Schmidt, et al.
Clinical Transplantation|November 15, 2006
FTY720 (fingolimod) in renal transplantationKlemens Budde, Manuela Schütz, Petra Glander, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2005
Limitations of C2 monitoring in renal transplant recipientsGunilla Einecke, Manuela Schütz, Ingrid Mai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipientsSusanne Brakemeier, Brunhilde Schweiger, Nils Lachmann, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patientsClaudia Sommerer, Sandra Müller-Krebs, Matthias Schaier, et al.
Clinical Transplantation|August 14, 2012
Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiographyLutz Liefeldt, Claudia Klüner, Petra Glander, et al.
Transplantation|June 4, 2014
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomesKaiyin Wu, Klemens Budde, Huber Lu, et al.
Journal of Clinical Pharmacology|May 29, 2007
Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritisDavid Czock, Franz Maximilian Rasche, Alexander Carius, et al.
Clinical Transplantation|June 12, 2018
Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantationPetra Glander, Johannes Waiser, Silke Kasbohm, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|May 28, 2004
Review of the immunosuppressant enteric-coated mycophenolate sodiumKlemens Budde, Petra Glander, Fritz Diekmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2010
The 'blood group O problem' in kidney transplantation--time to change?Petra Glander, Klemens Budde, Danilo Schmidt, et al.
Clinical Transplantation|November 15, 2006
FTY720 (fingolimod) in renal transplantationKlemens Budde, Manuela Schütz, Petra Glander, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2005
Limitations of C2 monitoring in renal transplant recipientsGunilla Einecke, Manuela Schütz, Ingrid Mai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipientsSusanne Brakemeier, Brunhilde Schweiger, Nils Lachmann, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patientsClaudia Sommerer, Sandra Müller-Krebs, Matthias Schaier, et al.
Clinical Transplantation|August 14, 2012
Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiographyLutz Liefeldt, Claudia Klüner, Petra Glander, et al.
Transplantation|June 4, 2014
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomesKaiyin Wu, Klemens Budde, Huber Lu, et al.
Journal of Clinical Pharmacology|May 29, 2007
Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritisDavid Czock, Franz Maximilian Rasche, Alexander Carius, et al.
Clinical Transplantation|June 12, 2018
Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantationPetra Glander, Johannes Waiser, Silke Kasbohm, et al.
Pageof 5